Vivere Italia on Nostr: Diabete tipo 2, semaglutide per via orale riduce attacchi cuore e ictus: lo studio
Published at
2025-03-29 20:15:09Event JSON
{
"id": "7930f02905f70032843e1d9754d974858e09c20dfba882f7562787296a6e5b7a",
"pubkey": "828744c7a7fdf42c8a4297437ad656e55d1eb71897b21ece33ad9ad23c0a2f48",
"created_at": 1743279309,
"kind": 1,
"tags": [
[
"proxy",
"https://vivere.uno/users/vivereitalia/statuses/114247552797413350",
"activitypub"
]
],
"content": "Diabete tipo 2, semaglutide per via orale riduce attacchi cuore e ictus: lo studio\nhttps://vivere.me/fNA2-m",
"sig": "600d09538ce135f78c779b53279083e365926373e01787983424d8b59e4f4bb77f9842bf3ebd08bfc6fd7cec924c7324252ba35d8ada040ce4d846f6242bb8f3"
}
